The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Hospira Inc

NYSE: HSP
Last

(U.S.) $89.08

Today's change+0.08 +0.09%
Updated July 7 2:33 PM EDT. Delayed by at least 15 minutes.
 

Hospira Inc

NYSE: HSP
Last

(U.S.) $89.08

Today's change+0.08 +0.09%
Updated July 7 2:33 PM EDT. Delayed by at least 15 minutes.

Hospira Inc up slightly

Hospira Inc is up just (U.S.)$0.08 today to (U.S.)$89.08. Over the last five days, shares have gained 0.42% and 45.44% year to date. Shares have outperformed the S&P 500 by 67.70% during the last year.

Key company metrics

  • Open(U.S.) $88.97
  • Previous close(U.S.) $89.00
  • High(U.S.) $89.17
  • Low(U.S.) $88.95
  • Bid / Ask(U.S.) $89.08 / (U.S.) $89.09
  • YTD % change+45.44%
  • Volume1,322,942
  • Average volume (10-day)1,525,791
  • Average volume (1-month)1,150,726
  • Average volume (3-month)1,288,596
  • 52-week range(U.S.) $46.56 to (U.S.) $89.17
  • Beta0.95
  • Trailing P/E45.00×
  • P/E 1 year forward29.72×
  • Forward PEG2.15×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.98
Updated July 7 2:33 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.10%

Based on its net profit margin of 7.10%, Hospira Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.41%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue1,1751,1271,1511,136
Total other revenue--------
Total revenue1,1751,1271,1511,136
Gross profit524394444426
Total cost of revenue651732707710
Total operating expense1,0421,0879231,036
Selling / general / administrative224191224211
Research & development135998676
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3264-9440
Other operating expenses, total--------
Operating income13340228100
Interest income (expense), net non-operating-15-18-19-19
Gain (loss) on sale of assets--------
Other--------
Income before tax1222220481
Income after tax743415562
Income tax, total48-124919
Net income763615971
Total adjustments to net income--------
Net income before extra. items763615971
Minority interest--------
Equity in affiliates2239
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items763615971
Inc. avail. to common incl. extra. items763615971
Diluted net income763615971
Dilution adjustment--00--
Diluted weighted average shares175173172170
Diluted EPS excluding extraordinary itemsvalue per share0.430.210.920.42
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.540.450.510.60